UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

DEPRESSIVE SYMPTOMS IN PATIENTS WITH DIFFERENT FORMS OF ALOPECIA: PREVALENCE AND STRUCTURE ANALYSIS

Type of Article

In the Section

Abstract

The purpose of the work is to study the prevalence and structure of depressive symptoms among patients with different types of alopecia.

The study included 153 women diagnosed with diffuse alopecia. Depending on the state of the mental sphere and the genesis of alopecia, 6 subgroups were formed: patients with metabolic alopecia without signs of maladaptation — G1-1 (30 patients), with metabolic alopecia with individual signs of maladaptation (risk group) — G1-2 (9), with metabolic alopecia and the presence of adaptation disorders — G1-3 (6 patients), with mixed alopecia without signs of maladaptation — G2-1 (15 patients), with mixed alopecia with separate signs of maladaptation (risk group) — G2-2 (64) and with mixed adaptation and adaptation disorders — G2-3 (29 patients).

Among alopecia patients, depression is a common problem that has been affected by more than a third of patients (37.9 %). The prevalence of depression depends significantly on the type of depression, and with mixed alopecia is three times higher than with metabolic (47.2 % against 15.6 %).

Some of the symptoms of depression are very common in patients with alopecia. The most common complaints are guilt, futility, anxiety or fear, cognitive disorders and sleep disorders. All symptoms of depression were more commonly found in patients with mixed alopecia.

The prevalence of depressive symptoms is closely associated with the degree of maladaptation. In a group of patients with severe manifestations, the prevalence of certain symptoms of depression exceeds 80 %, and clinically formulated depression disorder is present in two -thirds (68.6 %) of patients.

The prospects for further research are related to the comprehensive study of adverse changes in the psycho -emotional sphere of patients with different forms of alopecia, and the development of individualized measures of correction of depressive, anxiety and other psychopathological manifestations.

Pages

References

  1. Kranz D., Nadarevic L., Erdfelder E. Bald and Bad?: Experimental Evidence for a Dual-Process Account of Baldness Stereotyping,” Experimental Psychology, vol. 66, no. 5, pp. 340–354, Sep. 2019. doi: https://doi.org/10.1027/1618-3169/a000457.
  2. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J  Eur  Acad Dermatol Venereol. 2001 Mar;15(2):137-9. doi: https://doi.org/10.1046/j.1468-3083.2001.00229.x. PMID: 11495520.
  3. Cartwright T, Endean N, Porter A. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol. 2009 May;160(5):1034-9. doi: https://doi.org/10.1111/j.1365-2133.2008.09014.x. Epub 2009 Jan 20. PMID: 19183424.
  4. Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol. 2019 Jun;180(6):1377–1389. doi: https://doi.org/10.1111/bjd.17463. Epub 2019 Feb 21. PMID: 30501016.
  5. Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, Mesinkovska N, Ko JM, King BA, Wyrwich KW. You lose your hair, what’s  the big deal? I  was so  embarrassed, I  was so self-conscious, I was so depressed: a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020 Sep 11;4(1):76. doi: https://doi.org/10.1186/ s41687-020-00240-7. PMID: 32914253; PMCID: PMC7483696.
  6. Dhami L. Psychology of Hair Loss Patients and Importance of Counseling. Indian J Plast Surg. 2021 Dec  31;54(4). 411-415. doi: https://doi.org/10.1055/s-0041-1741037. PMID: 34984078; PMCID: PMC8719979.
  7. Aukerman EL, Jafferany M. The psychological consequences of androgenetic alopecia: A systematic review. J Cosmet Dermatol. 2023 Jan;22(1):89-95. doi: https://doi.org/10.1111/jocd.14983. Epub 2022 Apr 25. PMID: 35403805; PMCID: PMC10084176.
  8. Titeca G, Goudetsidis L, Francq B, Sampogna F, Gieler U, Tomas-Aragones L, Lien L, Jemec GBE, Misery L, Szabo C, Linder D, Evers AWM, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J, Dalgard FJ, Poot F. The psychosocial burden of alopecia areata and androgenetica: a cross-sectional multicentre study among dermatological out-patients in 13 European countries. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):406-411. doi: https://doi.org/10.1111/jdv.15927. Epub 2019 Nov 12. Erratum in: J Eur Acad Dermatol Venereol. 2020 May;34(5):1119. doi: 10.1111/jdv.16298. PMID: 31465592.
  9. Mesinkovska, Natasha & King, Brett & Mirmirani, Paradi & Ko, Justin & Cassella, James. (2020). Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study. Journal of Investigative Dermatology Symposium Proceedings. 20. S62- S68. https://doi.org/10.1016/j.jisp.2020.05.007.
  10. Marahatta S, Agrawal S, Adhikari BR. Psychological Impact of  Alopecia Areata  // Dermatol Res  Pract. 2020 Dec 24;24;2020:8879343. doi: https://doi.org/10.1155/2020/8879343. PMID: 33424962; PMCID: PMC7775172.
  11. Huang CH, Fu Y, Chi CC. Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia: A Systematic Review and Meta-analysis. JAMA Dermatol. 2021 Aug 1;157(8):963‐970. doi: https://doi.org/10.1001/jamadermatol.2021.2196. PMID: 34232264; PMCID: PMC8264758.
  12. Macbeth AE, Holmes S, Harries M, Chiu WS, Tziotzios C, de Lusignan S, Messenger AG, Thompson AR. The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care. Br J Dermatol. 2022 Jul;187(1):73-81. doi: https://doi.org/10.1111/bjd.21055. Epub 2022 May 11. PMID: 35157313; PMCID: PMC9542942.
  13. Psychodermatology. Medical and psychological aspects of psychosocial stress in clinical and aesthetic dermatological practice: monograph / Markova MV, Mukharovska IR, Lytvynenko MV [et al. Kharkiv, 2019. 277 p. [Psychodermatology. Medico-psychological aspects of psychosocial stress in clinical and aesthetic dermatological practice: monograph] / M.V. Markova, I.R. Mukharovska, M.V. Lytvynenko et al. Kharkiv, 2019. 277 p. (In Ukrainian).
  14. Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021 Jul;85(1):162–175. doi: https://doi.org/10.1016/j.jaad.2020.06.047. Epub 2020 Jun 17. PMID: 32561373; PMCID: PMC8260215.
  15. Tzur Bitan D, Berzin D, Kridin K, Cohen A. The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res. 2022 Jul;314(5).:463-468. doi: https://doi.org/10.1007/s00403-021-02247-6. Epub 2021 Jun 5. PMID: 34089375.